INVASIVE BLADDER PLASMACYTOID UROTHELIAL CARCINOMA

Clinical trials for INVASIVE BLADDER PLASMACYTOID UROTHELIAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new INVASIVE BLADDER PLASMACYTOID UROTHELIAL CARCINOMA trials appear

Sign up with your email to follow new studies for INVASIVE BLADDER PLASMACYTOID UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Scientists test Triple-Threat drug combo against Tough-to-Treat cancers

Disease control Ongoing

This early-stage study is testing the safety and best doses of a combination of cancer drugs for people with advanced cancers of the urinary system (like bladder and kidney cancer) that have spread. The trial combines a pill (cabozantinib) that aims to block tumor growth with one…

Matched conditions: INVASIVE BLADDER PLASMACYTOID UROTHELIAL CARCINOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

INVASIVE BLADDER PLASMACYTOID UROTHELIAL CARCINOMA

Get alerted when new INVASIVE BLADDER PLASMACYTOID UROTHELIAL CARCINOMA trials appear

Scientists test Triple-Threat drug combo against Tough-to-Treat cancers